Bailard, Inc. Wave Life Sciences Ltd. Transaction History

Bailard, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 18, 2019	BUY	$19.17 - $27.4 $38,340 - $54,800	2,000 Added 2.41%	85,000 $1.75 Million
Q2 2019 Jul 26, 2019	BUY	$22.93 - $42.84 $940,130 - $1.76 Million	41,000 Added 97.62%	83,000 $2.17 Million
Q1 2019 Apr 24, 2019	BUY	$32.69 - $47.91 $912,050 - $1.34 Million	27,900 Added 197.87%	42,000 $1.63 Million
Q4 2018 Feb 05, 2019	SELL	$37.1 - $50.11 $244,860 - $330,726	-6,600 Reduced 31.88%	14,100 $593,000
Q3 2018 Nov 13, 2018	SELL	$36.35 - $55.2 $218,100 - $331,200	-6,000 Reduced 22.47%	20,700 $1.04 Million
Q2 2018 Aug 08, 2018	SELL	$33.85 - $50.65 $880,100 - $1.32 Million	-26,000 Reduced 49.34%	26,700 $1.02 Million
Q1 2018 May 07, 2018	SELL	$32.45 - $54.7 $853,435 - $1.44 Million	-26,300 Reduced 33.29%	52,700 $2.11 Million
Q4 2017 Feb 08, 2018	BUY	$21.8 - $39.35 $1.72 Million - $3.11 Million	79,000	79,000 $0

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.29B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.